Last reviewed · How we verify

NCT05725603: TENDICICA

Clinical and Anatomical Evaluation of Healing of Lesions of the Subscapular Tendon

Status unknown NA Last updated 18 January 2024
What this trial tests

NA trial testing MRI imaging in Shoulder Injuries in 100 participants. Status unknown.

Timeline
12 September 2023
Primary endpoint
31 December 2024
31 December 2024

Quick facts

Lead sponsorGCS Ramsay Santé pour l'Enseignement et la Recherche
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment100
Start date12 September 2023
Primary completion31 December 2024
Estimated completion31 December 2024
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

GCS Ramsay Santé pour l'Enseignement et la Recherche — full company profile →

Who can join

18 and older, any sex, with Shoulder Injuries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is based on the hypothesis that fatty infiltration postoperative is not or only slightly modified after an atomic repair of lesions of the subscapularis tendon according to a new arthroscopic classification.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of MRI imaging

Trials testing the same drug.

Other recruiting trials for Shoulder Injuries

Currently open trials in the same condition.

Other GCS Ramsay Santé pour l'Enseignement et la Recherche trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05725603.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing